Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $31.02 USD
Change Today +0.59 / 1.94%
Volume 345.1K
EBS On Other Exchanges
Symbol
Exchange
Berlin
New York
As of 8:04 PM 05/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert G. Kramer Sr.

Chief Financial Officer, Executive Vice President of Corporate Services Division and Treasurer, Emergent BioSolutions, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 board members in 2 different organizations across 2 different industries.

See Board Relationships
57$1,917,987
As of Fiscal Year 2014

Background*

Mr. Robert G. Kramer, Sr. has been the Chief Financial Officer and Executive Vice President of Corporate Services Division at Emergent BioSolutions, Inc. since December 2012 and September 2012 respectively and serves as its Treasurer. Mr. Kramer is responsible for its legal affairs, strategic investments, human capital, management services and sales & marketing. He serves as the President and Chief Operating Officer of Ronald McDonald House of Outstate Michigan. Mr. ...

Read Full Background

Corporate Headquarters*

400 Professional Drive
Gaithersburg, Maryland 20879

United States

Phone: 240-631-3200
Fax: --

Board Members Memberships*

President, Chief Operating Officer and Director
Chief Financial Officer, Executive Vice President of Corporate Services Division and Treasurer
Director of Ronald McDonald House of Mid-Michigan

Education*

BS
Clemson University
MBA
Western Kentucky University

Other Affiliations*

Annual Compensation*

Salary$454,311
Bonus$205,199
Total Annual Compensation$659,510

Stock Options*

Restricted Stock Awards$731,211
All Other Compensation$7,800
Exercisable Options18,002
Exercisable Options Value$230,103
Unexercisable Options65,001
Unexercisable Options Value$164,512
Total Value of Options$394,615
Total Number of Options83,003

Total Compensation*

Total Annual Cash Compensation$667,310
Total Short Term Compensation$659,510
Other Long Term Compensation$739,011
Total Calculated Compensation$1,917,987
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EBS:US $31.02 USD +0.59

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
$860.0K
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$620.1K
William S. Marth Chief Executive Officer, President and Director
Albany Molecular Research Inc.
$982.5K
Peter William Grant Chief Executive Officer and Executive Director
Skyepharma PLC
567.0K GBP
M. Michelle Berrey M.D., MPH.Chief Executive Officer, President, Chief Medical Officer and Director
Chimerix, Inc.
$419.3K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EMERGENT BIOSOLUTIONS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.